API | itropride

itropride Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

Now

Chemistry

SMILES: COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC
InChIKey: QQQIECGTIMUVDS-UHFFFAOYSA-N
Mol. Mass: 358.44
ALogP: 2.57 Partition coefficient
ChEMBL Molecule:
itopride

More Chemistry

Pharmacology

Mechanisms of Action:
- Acetylcholinesterase (Homo sapiens) ^UniProt
- D(2) dopamine receptor (Homo sapiens) ^UniProt
- D(2) dopamine receptor (Canis lupus familiaris) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

ganaton | itopride | itopride hcl | itopride hydrochloride | itropride | n-(p-(2-(dimethylamino)ethoxy)benzyl)veratramide | n-(p-(2-(dimethylamino)ethoxy)benzyl)veratramide hydrochloride

Organizations (20)

Research & Development (20)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (11)

Approved Indications (1)

Gastroesophageal Reflux

Experimental Indications - Clinical Trial Phases 1-4 (11)

Blood Glucose (Phase 4)

Colonoscopy (Phase 3)

Constipation (Phase 4)

Dyspepsia (Phase 4)

Fatty Liver (Phase 2)

Gastroesophageal Reflux ()

Gastroparesis (Phase 1/Phase 2)

Healthy Volunteers (Phase 2/Phase 3)

Heartburn (Phase 3)

Irritable Bowel Syndrome (Phase 2)

Peritonitis (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 22
# of Trial Organizations: 20

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue